What is Ethicon?
Founded in 1915 and headquartered in Somerville, New Jersey, Ethicon is a long-standing provider of advanced surgical technologies and solutions. As a key component of Johnson & Johnson's Medical Devices Companies, Ethicon plays a critical role in advancing patient care through innovation in surgical instrumentation, energy devices, and advanced wound closure products. The company's extensive history and deep integration within a global healthcare leader position it as a significant player in the medical technology landscape.
How much funding has Ethicon raised?
Ethicon has raised a total of $71.7M across 7 funding rounds:
Series A
$4.5M
Private Equity
$1M
Private Equity
$14M
Private Equity
$8.2M
Series B
$14M
Debt
$4.8M
Series C
$25.3M
Series A (2008): $4.5M, investors not publicly disclosed
Private Equity (2009): $999K, investors not publicly disclosed
Private Equity (2012): $14M supported by H.I.G. Capital and H.I.G. BioVentures
Private Equity (2012): $8.2M, investors not publicly disclosed
Series B (2013): $14M, investors not publicly disclosed
Debt (2014): $4.8M, investors not publicly disclosed
Series C (2015): $25.3M led by Venture Investors, Versant Ventures, and H.I.G.BioVentures
Key Investors in Ethicon
Venture Investors
Venture Investors is likely a venture capital firm that focuses on investing in companies with high growth potential, possibly within the healthcare or technology sectors.
Versant Ventures
Versant Ventures is a venture capital firm specializing in investments within the healthcare and life sciences industries, often focusing on early-stage companies.
H.I.G. BioVentures
H.I.G. BioVentures is an investment firm with a specific focus on the biotechnology and life sciences sectors, providing capital for companies in these fields.
What's next for Ethicon?
The consistent and significant capital injections into Ethicon, spanning various funding types from Series A to Debt and Private Equity, indicate a mature company with ongoing strategic needs for growth and innovation. The recent major strategic investment suggests a focus on expanding market reach, developing next-generation surgical tools, or integrating new technologies. Ethicon's trajectory points towards continued leadership and expansion within the global surgical solutions market, leveraging its deep ties with Johnson & Johnson to drive future advancements.
See full Ethicon company page
